Pathology Experts LLC (PELLC) has formed a Board of Scientific Advisors (BSA) to provide the highest level of insight and advice to PELLC and its toxicologic pathology experts to meet the diverse challenges of its sponsors in the drug development and licensing arena. Sponsors include Pharmaceutical and Biotechnology companies.

The BSA includes 15 internationally recognized Life Sciences translational research professionals from industry, government and academia. The BSA will supplement Pathology Experts LLC's growing breadth of expertise in Toxicologic Pathology.

In addition, the BSA provides a wealth of practical knowledge regarding preclinical development, drug safety, NDA preparation and risk assessment of potential products. This knowledge pool adds depth of expertise in organ systems and therapeutic areas to provide additional value-add to PELLC's client sponsors. The BSA is part of our support system to insure that Pathology Experts LLC offers our sponsors the highest level of expertise available.

"Our Board of Scientific Advisors consists of some the world's leading toxicologic pathologists and toxicologists, many of whom are recognized as being the top-ranked authorities in their specific areas of expertise today. Pathology Experts' BSA is unique in that it can be called upon for opinions regarding active projects on an as-needed basis. We believe that our association with this esteemed group of globally recognized top-level scientists and translational researchers support our efforts to deliver the best in class services to our sponsors." Dr. Maurice Cary, founder and CEO of Pathology Experts LLC

About Pathology Experts LLC
Pathology Experts LLC is a privately held consulting firm consisting of senior level, expert, toxicologic pathologists who service the histopathology, toxicology and preclinical research needs of Life Sciences companies in Europe and North America.

These customers require the caliber of expertise offered by PELLC to support critical, time sensitive decision making concerning compounds in the preclinical and Phase I stages of development and beyond. Our focus is on delivering high quality and high value service to our clients to meet their corporate milestones. PELLC provides peer review and troubleshooting expertise to clients, as well as GLP certified histopathology, regulatory document preparation, study placement and monitoring, and due diligence in support of M&A and licensing activities where detailed assessments of compounds in development represent a significant portion of the value of the transaction.

PELLC Experts are available for assignments in North America and Europe with offices in Basel Switzerland, Harrison NY and San Francisco CA.

For further details on services and additional information, please visit our website www.pathexperts.com. or call 888-473-4554 ext 10.